Related Experiment Videos
Caffeine intake in outpatients with schizophrenia
Manuel Gurpegui1, M Carmen Aguilar, José M Martínez-Ortega
1Department of Psychiatry and Institute of Neurosciences, University of Granada, Spain.
Schizophrenia Bulletin
|June 15, 2005
Summary
High caffeine intake in schizophrenia patients is linked to smoking and alcohol use, not symptom severity. This study clarifies caffeine consumption patterns in this population, considering confounding factors like tobacco use.
Area of Science:
- Psychiatry
- Clinical Psychology
- Neuroscience
Background:
- Previous research indicates high caffeine consumption in schizophrenia patients.
- Some studies suggest caffeine may worsen schizophrenia symptoms.
- Existing research often fails to account for tobacco smoking's impact on caffeine metabolism.
Purpose of the Study:
- To investigate the relationship between caffeine intake and tobacco/alcohol use in schizophrenia patients.
- To determine if caffeine consumption correlates with schizophrenia symptom severity.
- To address limitations in prior studies by controlling for smoking and alcohol use.
Main Methods:
- A study of 250 outpatients diagnosed with DSM-IV schizophrenia in Granada, Spain.
- Assessment of caffeine, tobacco, and alcohol consumption patterns.
- Evaluation of cross-sectional schizophrenia symptomatology.
Main Results:
- 59% of patients consumed caffeine.
- Caffeine intake was significantly associated with current smoking and alcohol use.
- Among caffeine consumers, smoking correlated with the amount of caffeine consumed.
- No association was found between caffeine intake and schizophrenia symptom severity.
Conclusions:
- Caffeine consumption in schizophrenia patients is linked to substance use, particularly smoking and alcohol.
- The high prevalence of smoking may explain elevated caffeine intake in this population.
- Caffeine intake does not appear to be directly associated with the severity of schizophrenia symptoms.